Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.
Estrogen signaling plays a critical role in the pathogenesis of breast cancer. Because the majority of breast carcinomas express the estrogen receptor ERα, endocrine therapy that impedes estrogen-ER signaling reduces breast cancer mortality and has become a mainstay of breast cancer treatment. Howev...
Main Authors: | Ada Ao, Brian J Morrison, Heiman Wang, J Alejandro López, Brent A Reynolds, Jianrong Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-04-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3077404?pdf=render |
Similar Items
-
A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
by: Léa Clusan, et al.
Published: (2021-01-01) -
A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen Responsiveness
by: Kendall L. Langsten, et al.
Published: (2023-12-01) -
Antiestrogenic Activity of the Xi-Huang Formula for Breast Cancer by Targeting the Estrogen Receptor α
by: Jian Hao, et al.
Published: (2018-07-01) -
Estrogenic or antiestrogenic therapies for multiple myeloma?
by: Renoir Jack-Michel, et al.
Published: (2007-09-01) -
Response of Symbiotic Endomycorrhizal Fungi to Estrogens and Antiestrogens
by: Marie-Josée Poulin, et al.
Published: (1997-05-01)